Financial reports
ARS
2023 FY
Annual report to shareholders
17 Apr 24
10-K
2023 FY
Annual report
20 Mar 24
10-Q
2023 Q3
Quarterly report
8 Nov 23
10-Q
2023 Q2
Quarterly report
11 Aug 23
10-Q
2023 Q1
Quarterly report
10 May 23
10-K
2022 FY
Annual report
22 Mar 23
10-Q
2022 Q3
Quarterly report
10 Nov 22
10-Q
2022 Q2
Quarterly report
10 Aug 22
10-Q
2022 Q1
Quarterly report
11 May 22
10-K
2021 FY
Annual report
30 Mar 22
Current reports
8-K
Rani Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results; Provides Corporate Update
20 Mar 24
8-K
Rani Therapeutics Announces Positive Topline Results from Phase 1 Study of
5 Feb 24
8-K
Departure of Directors or Certain Officers
19 Dec 23
8-K
Other Events
14 Dec 23
8-K
Rani Therapeutics Reports Third Quarter 2023 Financial Results; Provides Corporate Update
8 Nov 23
8-K
Entry into a Material Definitive Agreement
1 Nov 23
8-K
Other Events
25 Oct 23
8-K
Rani Therapeutics Announces Successful Drug Delivery of High-Capacity Pill in Preclinical Studies
7 Sep 23
8-K
Rani Therapeutics Reports Second Quarter 2023 Financial Results; Provides Corporate Update
11 Aug 23
8-K
Entry into a Material Definitive Agreement
5 Jun 23
Registration and prospectus
S-8
Registration of securities for employees
20 Mar 24
S-8
Registration of securities for employees
22 Mar 23
424B7
Prospectus with selling stockholder info
29 Dec 22
S-3
Shelf registration
16 Dec 22
424B5
Prospectus supplement for primary offering
25 Aug 22
424B5
Prospectus supplement for primary offering
10 Aug 22
S-3
Shelf registration
1 Aug 22
S-8
Registration of securities for employees
31 Mar 22
S-8
Registration of securities for employees
3 Aug 21
424B4
Prospectus supplement with pricing info
2 Aug 21
Other
EFFECT
Notice of effectiveness
30 Dec 22
CORRESP
Correspondence with SEC
27 Dec 22
UPLOAD
Letter from SEC
22 Dec 22
EFFECT
Notice of effectiveness
11 Aug 22
CORRESP
Correspondence with SEC
10 Aug 22
CORRESP
Correspondence with SEC
10 Aug 22
CORRESP
Correspondence with SEC
9 Aug 22
UPLOAD
Letter from SEC
3 Aug 22
EFFECT
Notice of effectiveness
30 Jul 21
CERT
Certification of approval for exchange listing
29 Jul 21